Filing Details

Accession Number:
0001415889-23-008197
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-05-17 16:17:15
Reporting Period:
2023-05-15
Accepted Time:
2023-05-17 16:17:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1109354 Bruker Corp BRKR Laboratory Analytical Instruments (3826) 043110160
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1133649 H Frank Laukien C/O Bruker Corporation
40 Manning Road
Billerica MA 01821
President & Ceo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-05-15 137,718 $72.60 38,352,034 No 4 S Direct
Common Stock Disposition 2023-05-15 47,657 $73.18 38,262,287 No 4 S Direct
Common Stock Disposition 2023-05-16 12,917 $73.03 38,210,993 No 4 S Direct
Common Stock Disposition 2023-05-16 1,708 $73.68 38,180,634 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,046,499 Indirect By Former Spouse
Common Stock 337,087 Indirect By Son
Common Stock 336,607 Indirect By Daughter
Common Stock 201,702 Indirect As UTMA Custodian for Son
Common Stock 71,728 Indirect As UTMA Custodian for Son
Common Stock 492 Indirect By Former Spouse
Footnotes
  1. The shares represented by this transaction were sold pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.00 to $73.00, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.01 to 73.71, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.59 to $73.58, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.59 to $73.78, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  6. The Reporting Person disclaims beneficial ownership of 1,046,499 shares held by the Reporting Person's former spouse- Robyn Laukien, 492 shares held by the Reporting Person's former spouse- Ruta Laukien, 337,087 shares held by the Reporting Person's adult son and 336,607 shares held by the Reporting Person's adult daughter, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.